Bill > SB1640

This bill makes several changes to Arizona's laws regarding marijuana, particularly concerning medical marijuana. It expands the list of qualifying debilitating medical conditions to include post-traumatic stress disorder, autism spectrum disorder, uterine fibroids, endometriosis, and ovarian cysts, and clarifies that a "cardholder" can be an independent third-party laboratory agent. The bill also introduces new regulations for testing marijuana and marijuana products, requiring independent third-party laboratories to upload test results to a state portal within five days and establishing rules for batch sizes, unique batch numbers, and sampling procedures, with specific requirements for sample collection and record-keeping starting in 2028. Additionally, it caps the application fee for qualifying patients at $25 and exempts honorably discharged veterans from this fee, while also mandating that funds from the medical marijuana fund be used for grants for marijuana clinical trials and other public health initiatives. The bill also updates labeling requirements for marijuana products to include a scannable code linking to detailed product information, including laboratory test results, and establishes procedures for handling public complaints against marijuana-related entities, ensuring confidentiality for complainants while allowing disclosure to relevant government agencies for investigations.

Health and Social Services

https://apps.azleg.gov/BillStatus/BillOverview/85279